logologo
QuantliQuantli

Prokidney Corp

PROK

NASDAQ

Biotechnology

$1.33

USD

-0.08 (-5.34%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $424.02M

Volume 1.4M

Price Target

$12.00$12.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $12.00 and a min estimate of $12.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$12.00

Implied Upside

+802.3%

Analyst Covering

1

Consensus

Buy

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Joseph Pantginis

HC Wainwright & Co.

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

CAPR

Capricor Therapeutics Inc

$6.65

+58.0%

XFOR

X4 Pharmaceuticals Inc

$4.22

-1.6%

FENC

Fennec Pharmaceuticals Inc

$11.72

-2.8%

RCKT

Rocket Pharmaceuticals Inc

$3.47

+3.9%

EDIT

Editas Medicine Inc

$2.82

+0.4%

ENTA

Enanta Pharmaceuticals Inc

$13.16

-2.1%

LXEO

Lexeo Therapeutics Inc

$4.84

-2.4%

BNTC

Benitec Biopharma Inc

$12.56

0.0%

CMPX

Compass Therapeutics Inc.

$2.25

-0.4%